NASDAQ · Biotechnology

SLS (SLS) Stock

$10.84 -4.28% NASDAQ: SLS Healthcare

Valuation

MetricValue
Price$10.84
Market Cap$2.02B
P/E Ratio-24.00
P/B Ratio12.03
P/S Ratio0.00
EPS (TTM)$-0.25
52-Week High$15.45
52-Week Low$1.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.03%
ROA-34.62%
ROCE-39.44%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio10.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$1.0M$0$0$0
Operating Profit$-25.0M$-42.0M$-38.0M$-32.0M$-28.0M
Net Profit$-21.0M$-41.0M$-37.0M$-31.0M$-27.0M
EPS$-1.34$-2.13$-1.34$-0.50$-0.25
Op Margin-332.8%-4195.0%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$26.0M$21.0M$6.0M$19.0M$78.0M
Total Liabilities$6.0M$16.0M$14.0M$10.0M$7.0M
Cash$21.0M$17.0M$3.0M$14.0M$72.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$1.0M

Latest News

SLS Stock Tracks Worst Month Since March: Investor Slashes Stake By Over 30% As Quiet Period Begins Ahead Of AML Readout Stocktwits · Jul 22, 2026 SLS Stock Rises Overnight: Retail Thinks CEO Just Dropped Buyout Clues Ahead Of Fox Appearance Stocktwits · Jul 21, 2026 SLS Stock Jumps Ahead Of CEO’s Fox Appearance: Retail Bets AML Readout Could Spark Big Pharma Bidding War Stocktwits · Jul 20, 2026 Will Near-Complete REGAL Phase 3 GPS Data and New Executive Terms Change SELLAS Life Sciences Group's (SLS) Narrative Simply Wall St. · Jul 18, 2026 SELLAS Life Sciences Group (SLS) Stock Looks Rich On Book Value Yet Strong On Returns Simply Wall St. · Jul 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-26.0M$-24.0M$-31.0M$-35.0M$-28.0M
Investing Cash Flow$0$-9.0M$-11.0M$0$0
Financing Cash Flow$3.0M$0$0$1.0M$-1.0M
Net Cash Flow$-14.0M$-4.0M$-15.0M$11.0M$58.0M
Free Cash Flow$-26.0M$-28.0M$-37.0M$-35.0M$-28.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-2.71%
Quick Ratio17.22
Interest Coverage—
Return 1Y556.52%
Return 3Y614.79%
Return 5Y37.59%

Ownership

Insiders Held0.95%
Institutions Held27.84%
Institutions Float Held28.11%
Institutional HolderSharesReport Date
Blackrock Inc.12,198,4102026-03-31
State Street Corporation8,396,3562026-03-31
Vanguard Capital Management LLC7,525,9292026-03-31
Geode Capital Management, LLC3,912,6062026-03-31
Marshall Wace LLP2,037,1622026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARMPArmata Pharmaceuticals, Inc. $4.64 -0.43% -0.60 $170.34M 0.00%
CCCC $3.52 -0.85% -2.54 $389.20M 0.00%
CDXS $1.47 -2.00% -5.06 $133.62M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
IVVD $0.55 +3.10% -3.53 $162.51M 0.00%

About SLS

SLS is led by CEO Angelos Stergiou, employs 15 people, headquartered in US, publicly traded since 2008.

SLS stock trades at $10.84 with a market capitalization of $2.02B. The stock is valued at a price-to-earnings (P/E) ratio of -24.00, price-to-book of 12.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.39 and $15.45, and currently trades 29.8% below its 52-week high.

On profitability, SLS generates a return on equity (ROE) of -38.03%, return on capital employed of -39.44%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides